PECARN Pediatric Head Injury/Trauma Algorithm

PECARN Pediatric Head Injury/Trauma Algorithm

Guides CT use in children with minor head trauma

PECARN Pediatric Head Injury/Trauma Algorithm

PECARN Pediatric Head Injury/Trauma Algorithm

Guides CT use in children with minor head trauma

Patient & pathway
Age drives PECARN pathway. High-risk → CT; Intermediate → Observation vs CT; Low-risk → No CT.
Pathway: < 2 years
High-risk (CT recommended)
GCS ≤14 or altered mental status
Intermediate risk (Observation vs CT)
Severe mechanism (any):
Severe if > 3 ft — enter height
CT not recommended (PECARN low risk)
< 2 years pathway · <0.02% ciTBI risk · High: No · Intermediate: No

Instructions

The PECARN (Pediatric Emergency Care Applied Research Network) Pediatric Head Injury Algorithm helps clinicians decide when a child with head trauma should receive a CT scan or can be safely managed without imaging. It applies to patients younger than 18 years presenting within 24 hours of blunt head injury.

If high-risk features are absent, evaluate for intermediate-risk predictors. For children under 2 years, these include nonfrontal scalp hematoma, loss of consciousness for 5 seconds or longer, severe mechanism of injury, or parental report that the child is not acting normally. For children aged 2 years or older, these include any loss of consciousness, vomiting, severe headache, or severe mechanism of injury.

When intermediate-risk predictors are isolated, symptoms are stable or improving, the child is at least 3 months old, and there is low clinician concern, observation is preferred over CT. Escalate to CT if there are multiple predictors, if the patient is very young, or if there is any clinical deterioration during observation.

Overview
When to use
Why use
Evidences
  • Derivation and validation study: Kuppermann et al. prospectively enrolled >42,000 children; <2 years rule 100% sensitivity/NPV for ciTBI, ≥2 years rule 96.8% sensitivity and 99.95% NPV; neither rule missed neurosurgical cases in validation sets.

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(09)61558-0/abstract

  • CDC Pediatric mTBI Guideline: advises against routine imaging and endorses validated decision rules (like PECARN) to identify low-risk children, reporting PECARN NPV 99.9% and sensitivity 96.8% in ≥2 years and 100% in <2 years cohorts, with independent validations confirming high performance.

https://www.cdc.gov/traumatic-brain-injury/hcp/clinical-guidance/index.html

  • Implementation study: EHR-integrated PECARN decision support reduced head CT rates from 26% to 13% without increase in missed ciTBI or ED return visits, supporting safe adoption at scale.

https://pmc.ncbi.nlm.nih.gov/articles/PMC6132459/

  • Evidence summary and clinical calculator: PECARN shows age-stratified risk estimates and high sensitivity; outperforms CHALICE and CATCH for ciTBI in some validations, enabling safe CT reduction with observation pathways.

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(17)32153-0/fulltext

Overview
When to use
Why use
Evidences

Head injury is one of the most common reasons for pediatric emergency visits, but most cases do not involve significant brain injury. CT scans are the most accurate way to detect intracranial bleeding or fractures, but they expose children to ionizing radiation, which increases lifetime cancer risk.

The PECARN rule, developed through the largest prospective pediatric head trauma study to date, offers evidence-based criteria to minimize unnecessary CT scans without missing clinically important brain injuries. The algorithm uses a small set of high- and intermediate-risk factors tailored to each age group.

For children under 2 years, risk factors include signs of skull fracture, non-frontal scalp hematomas, severe injury mechanisms and abnormal mental status. For children 2 years and older, risk factors include severe headache, vomiting, loss of consciousness and signs of skull fracture.

By following the PECARN rule, clinicians can improve diagnostic accuracy, protect children from unnecessary radiation exposure and make care more efficient in emergency settings.

Overview
When to use
Why use
Evidences
  • Derivation and validation study: Kuppermann et al. prospectively enrolled >42,000 children; <2 years rule 100% sensitivity/NPV for ciTBI, ≥2 years rule 96.8% sensitivity and 99.95% NPV; neither rule missed neurosurgical cases in validation sets.

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(09)61558-0/abstract

  • CDC Pediatric mTBI Guideline: advises against routine imaging and endorses validated decision rules (like PECARN) to identify low-risk children, reporting PECARN NPV 99.9% and sensitivity 96.8% in ≥2 years and 100% in <2 years cohorts, with independent validations confirming high performance.

https://www.cdc.gov/traumatic-brain-injury/hcp/clinical-guidance/index.html

  • Implementation study: EHR-integrated PECARN decision support reduced head CT rates from 26% to 13% without increase in missed ciTBI or ED return visits, supporting safe adoption at scale.

https://pmc.ncbi.nlm.nih.gov/articles/PMC6132459/

  • Evidence summary and clinical calculator: PECARN shows age-stratified risk estimates and high sensitivity; outperforms CHALICE and CATCH for ciTBI in some validations, enabling safe CT reduction with observation pathways.

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(17)32153-0/fulltext

Frequently Asked Questions

Features and Services FAQs

Discover the full range of features and services we offer and how to use them.

Can PECARN be used for adults?+
What is considered a severe mechanism of injury?+
Does a high PECARN risk always mean CT is mandatory?+
Can observation replace CT in intermediate-risk patients?+
What counts as abnormal mental status?+
Does vomiting alone mean CT is required?+

Ready to Transform Your Practice?

Join thousands of clinicians saving hours daily with AI-powered documentation.

14-day free trial • No setup fees

Ready to Transform Your Practice?

Join thousands of clinicians saving hours daily with AI-powered documentation.

14-day free trial • No setup fees

Ready to Transform Your Practice?

Join thousands of clinicians saving hours daily with AI-powered documentation.

14-day free trial • No setup fees

DocScrib

AI-powered medical documentation platform revolutionizing clinical workflows through intelligent patient management and secure documentation.

© 2025 DocScrib. All rights reserved.

DocScrib

AI-powered medical documentation platform revolutionizing clinical workflows through intelligent patient management and secure documentation.

© 2025 DocScrib. All rights reserved.

DocScrib

AI-powered medical documentation platform revolutionizing clinical workflows through intelligent patient management and secure documentation.

© 2025 DocScrib. All rights reserved.